financetom
Business
financetom
/
Business
/
Core Molding Technologies Insider Sold Shares Worth $257,340, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Core Molding Technologies Insider Sold Shares Worth $257,340, According to a Recent SEC Filing
Dec 23, 2024 3:24 PM

05:46 PM EST, 12/23/2024 (MT Newswires) -- David L. Duvall, Director, Chief Executive Officer, on December 18, 2024, sold 15,919 shares in Core Molding Technologies ( CMT ) for $257,340. Following the Form 4 filing with the SEC, Duvall has control over a total of 257,512 shares of the company, with 257,512 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1026655/000102665524000143/xslF345X05/wk-form4_1734993839.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amylyx Pharmaceuticals Prices $60 Million Common Stock Offering
Amylyx Pharmaceuticals Prices $60 Million Common Stock Offering
Jan 10, 2025
09:10 AM EST, 01/10/2025 (MT Newswires) -- Amylyx Pharmaceuticals ( AMLX ) said Friday it priced an underwritten offering of about 17.1 million common shares at $3.50 per share. The company also said it gave the underwriter a 30-day option to buy up to an additional 2.6 million shares at the offering price. Gross proceeds are expected to be about...
Teva Pharmaceutical, Samsung Bioepis to Commercialize Epysqli in US
Teva Pharmaceutical, Samsung Bioepis to Commercialize Epysqli in US
Jan 10, 2025
09:15 AM EST, 01/10/2025 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) and Samsung Bioepis said Friday that they have signed an agreement to develop and commercialize Epysqli, Samsung Bioepis' biosimilar to Alexion Pharmaceuticals' Soliris, in the US. Under the terms of the deal, Samsung Bioepis will oversee the development, regulatory registration, manufacture, and supply of Epysqli, while Teva...
Delta Beats Fourth-Quarter Estimates, Forecasts Double-Digit Earnings Growth in 2025
Delta Beats Fourth-Quarter Estimates, Forecasts Double-Digit Earnings Growth in 2025
Jan 10, 2025
09:11 AM EST, 01/10/2025 (MT Newswires) -- Delta Air Lines ( DAL ) reported better-than-expected fourth-quarter results on Friday amid robust travel demand while the carrier said it expects full-year earnings growth of over 10%. Adjusted earnings came in at $1.85 per share for the December quarter, up from $1.28 the year before, surpassing the FactSet-polled consensus of $1.76. Operating...
Warner Bros. Discovery, Disney Unit, Fox Scrap Plans to Launch Venu Sports Streaming Service
Warner Bros. Discovery, Disney Unit, Fox Scrap Plans to Launch Venu Sports Streaming Service
Jan 10, 2025
09:15 AM EST, 01/10/2025 (MT Newswires) -- Warner Bros. Discovery ( WBD ) Walt Disney's ( DIS ) ESPN ( DIS ) unit, and Fox (FOX, FOXA) said in a joint statement Friday they have decided not to move forward with their planned Venu sports streaming service. The companies determined that focusing on their existing products and distribution channels better...
Copyright 2023-2026 - www.financetom.com All Rights Reserved